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AtrM natriuretie pPptide alters left venlricuiar p~lrormance in 
paltents wtth heart failure. To BSHSS the direct eflets of this 
hormone cn myocardtnt Lnctton, ils acttons were compared with 
tb16e of the pure wwdtttor nitmpruaide in 10 patients ~4th 
heart feilure. Simulteneous lell ventricular mkremanameter 
prea!xe and redionuclide volume were obtained during a baseline 
triad, during rdtreprwide iefesian, during a weld beseliie 
period and during atria, oatriuretic peptide i&&n. The bawline 
Pcd-SjaUk pi*iurcVtiunle ~laikm ii0 &,?,ii;&ed in i;tZZ pa- 
tierde from pressere.volume laop~ obtained during the hue base. 
line periods and during afterload reducban :rith nitropresside. 
Mean arterial pressure deweeeed with alrial oalrhxetic oeo- 
tide (89 f 3 to 8il i 2 mm Hg, p < o.05) and bye greeter mu& 
witb nitmprvsside (90 L 4 to 73 + 3 mm Hg, p < 0.06). Leff 
wdriculnr end-Sstolic pressure eke decreased with atrisl natri- 
uretic pptide (24 f 2 to 16 f 3 am Hg, p < 0.63) end by a 
gweler ameunt with nitraprusside (24 t 2 lo 13 zt 3 mm Hg, p < 
0.05). Cerdiec index increased during inloslon of each sgent liom 
2.0 f 0.2 to 2.4 t 0.2 literelmio per m’ (p < 0.01). Heart rate 
Arrial natriuretic peptide is a 28amino acid peptide released 
by atria1 myocytes in response to stretch (I,& It induces 
diuresis, nalriuresis, varodilation and inhibition of aldoste- 
rone secretion in normal humans (3-S). In response to atrial 
nauiuretic peptide, stroke volume decreases (6-13) or does 
not change (3,141 in animals or humans with normal left 
ventricular svstolic function. In contrast. atria1 natriurelic 
peptide in&es stroke volume in patients with hean fail- 
ure, with a simultaneous decrease in pulmonary capillary 
wedge pressure (3,l4-18). 
Although it has been demooslmtcd that the wodilator 
increased slightly with nitropnsside but did nol change with strial 
natriurelic peptide. Peak pwitive timt derivative of I& ventricu- 
tar pros~ure (dT/dt), e,e&m fmc,io” and ,truke work index were 
vnchenged by either agent. The reletion between end.systelie 
pressure and volume during ntriel nrtriuretic peptide infusion wes 
shIlled sliihlly lollward fram the baseline velue in four patients, 
slightly rightward in lenr end net et eU In one patient, indicating 
no cenaielent ioeSrep!c e&t, Both egents sherteoed the tbne 
&xGxd et &pji.“.‘iT&~ r&x-;:iw. c&&ed by t:d lcgtitbmic 
method, but ocdy rdtmprueside shortened the lime eenstent Cal- 
adsted by the derivatbe method. Peak frliiog late was unehangtd 
from hauline with either age”,. Atrial nntriureHc poptide did not 
shill the end.diatolic pre~ure+wlume point away from the 
relation ewstrwted Irem baeellne and nitrepruseide peiats. 
It Is rmctuded tbd atrbd natrturetie pep4ide hs no direct 
e&et en myeeerdiel cenlractile er dbatelie function in petierds 
with heert feibue. 
(1 Am Cell Cd&f 199&20:96-I?hJ 
action of atrial natriuretic peptide accounl~ in part for its 
hemodynamic eEectr, there has been cootioued spectdation 
regardingpossibledirecteffectsofthe peptide on myocardial 
contractile and diastolic function. It has been suggested (IS) 
that the increase in cardiac index seen in response to atrial 
natriorelic peplide infusion in patients with heart failore is 
due to B positive inolropic effect. In contrast, the decrease in 
stroke volume shown in some studies of subjects with 
oonoal ejection fraction has led other investigators (7,l I) to 
postulate that atrial nauiuretic peptide exerts a negatiw 
inolropic effect. A negative inotmpic effect would explain 
the decrease in stroke volume index without a change in 
preload observed during atrial nattiuretic peptide infusion in 
patients with hypertension (7). Studies io cat papillary mue- 
cles (19) and isolated perfused heerts (20) have suggested 
such a negative inotmpic effect of atrial natriuretic peptide, 
whereas a stody in the chronically instrumented conscious 
dog found no iootmpic effect (21). It has also been absened 
(19) that atrial natriuretic peptide causes early relaxation of 
cat papillary muscle. Thus, the hemodynamic effects of this 
psptide could be due in port to direcl influences on myow 
dial wntmctile or diastolic function, or ‘00th 
In sludies of the intact circu’ation. it IE difRxlt to rsohu~ 
the inotropic effect of an agent that alters preload or aftcr- 
load. or both, because most measures of systolic functron 
are influenced by loading condiuons. ihe end-systolic pres- 
sure-volume relation is a relatively !oad-mdependent mea- 
sure of left ventricular COIItrrlctde function (22.23) ThC 
baseline end-systolic pressure-volume relation can be gensr- 
ated in patients with heart fadure by infusion of nitroprusside 
(24); the inotropic acttons of a drug can be judged from B 
drug-induced shift away from the baselute rcldtlcn i25.?6l. 
Indexes of diastolic function are also mfluexed by changes 
in loading conditions as well as by direct nyocardia! enects 
127). Thr direct actions of an agent on mycrardial diastolic 
propen& may bc inferred from a compartror. of its effects 
with those of a “pure” vnsodilator such as ttitroprusside 
I28.29). 
Therefore, to determine whether atrial natnnretic peptide 
has direct effects on myocardial contractile and diastolic 
function. we sequentially administered nitroprusside and 
atrial natriuretic ptptide to 10 patients with chronic hean 
failure. 
Methods 
Studv natients. The studv erouo comorised IO uarients: 7 
men and 3 women, aged S8.<4 &an 1 SEMt yesrs, with 
chronic New York Hesrt Association. class II to !V heart 
lailure due to either coronary artery disease (5 patients) or 
idiopathic dilated cardiomyopathy (5 pattents). All patients 
were treated with dig&t, diuretic drug> end uawdilatots; 
seven also received antiarrhythmic medication for ventricu- 
lar arrhythmias. Radionuclide lefi ventriculat ejection fret. 
rion we.sO.i4 r 0.01 (rungeO.lOto0.20l. All patients were in 
sinus rhvthm. The studv rrotocol was approved bv the 
Subcom&ttee cm Huma?‘Studies of thi ~Massachusetts 
General Hoseital on Setnember IS. 1987: written. informed 
consent was obtained from an patients. 
Hemodyoamic moastuements. Diguxin. diuretic drugs 
and vasodilators were discontinued I2 to 24 tt before cathe- 
terization; at&nrhythmic therapy -as continued. No pre- 
medication was given. Left heart cathe!eriration was per- 
formed by the femoral approach with a micromanometer- 
tipped catheter(Yillar Instruments) in nine patients and with 
a fluid-filled catheter Zn one patient (Patient I). Right heart 
catheterization was performed from the internal juguler vein 
with ts triple-lumen balloon-tipped themtodilution catheter. 
The folkwing hemodynnmic variables -we recorded: 
heart rate, right atrial pressur?. pulmonary artery pressure. 
pulmonary capillary wedge pressure, left mntticular pres- 
sure, mean systemic arterial pressure, and. in eight patients. 
firrt derivative of left ver.tricular pressure (dl’ldt) (by elec- 
tronic diierentiatiunj. Left re~ricular dP/dt wxs not re- 
corded in Patient I, who had a fluid-filled catheter. or in 
F&nt 9. because of a technical error. ,Jardiac output was 
delennined by the tbeaiodilution lecbniqoe in eight patients 
and by the Fick oxygen technique in two. Calculations were 
made by urmg the fol:owing formulas: Cardiac index (htersl 
mm per m’r = Kerdizc Outpm)~tRody Surface Area): Stroke 
Volume Index (mllm*l = (Cardiac Indexl!lHeafi Rate); 
Stroke Work lnder tg-mlm’t = tO.rJl36) (Mean Arterial Pres- 
sure - Left Ventricular End-Diastolic Pressure3!Srroke 
Vohmre indeil): Systmtnic Vascular Resistance (dynes-s&t 
= Ktl:Meae Systemic Arterial Pressure - Right Atrisi Pres- 
sure):tCarJurc Qutputj; and Puinonary Vascular Resistance 
ldynes-s/cm’] = 80 (,Mean Pulmonary Artery Pressure - 
Puimocary Capillary Wedge Pressure:i(Cardiac Output). 
The loporidmic rime conrltmt ofief; wxricular rsowlu- 
mc!nc relararion (T,) was calculated from the rmcromacore- 
eter-obtained left &ricular pressure by rhe method of 
Weiss et al. 130). The period ofisovolurrtetric relaxarron WB 
taken io he from the aortic dicrotic notch pressure to thr 
pressuie corresponding to the peak of the v wave of the 
simuitaneous pulmonery capillary aedge treeing. The nega- 
rive reciprocal of the slope oi the linear fit ofln(left ventrio 
uiar oressure) versus time defmed T.. The &xivativz time 
constant T, was calculated by the metihod of%n and diatttz 
OI) duritrg the same time intetvl as T. from the neeillive 
rectproca~of the slope of L linear fit of l&t venuicul.&dPldt 
versus pressure. This method allows for B non-zero pressure 
asysptote. P.. 
Hemodynamic data were obtained during a baseline pe- 
riod. during cotrste~t iofusion of nitmpnriwids. bring a 
secooo baseline period and during atrial natriuwtic peptide 
infusion. Nttropturside ~8s infused initisliy at a rate of 
25 &mm. which was titrated upward to achieve a 15. to 
20.mm Hg decrease in mean arterial pressure. Measure- 
ments during nitropmsside ittfusion were made 5 rnin after 
the desired hemodynamic effect was achieved. ar?d baseiine 
measurements were repeated IO mitt after tthroprusside was 
discontinued, when hem&n&c variables matched those 
in the first baseline period. Anaritide (Wyeth-Ayerst Lab+ 
ratories) is a synthetic 25-amino acid peptide (human attrd 
natriuretic peptide 102-1263 thdt lacks 3 amino rcidr from 
tbe xeino terminus of human atrial natriuretic peptide. and 
has similar btologic activity (investigational brochure, 
Wyeth Laboratories. 1985). ‘The e!riaI natriuretic peptide 
infuss . was titrated either to achieve a decretuett: in mean 
arterial pressure similar to that abtained during the nitre- 
prusside infusion or io achieve a maximal tzk of 0.6 .@kg 
per min. Measurements were made at least IO mitt after the 
final infusmn ate of atrial natriwetic peptide was bcgon. 
Radioouetide semming. Left ventricular vohtme was cef- 
elated from gated blood pool images in nine patients as 
pxviously &scribed (24-26.28). Images were not recorded 
in Pot&t IO because of a technical error. After in viva 
labeling of the patient‘s red blood cells with stamtous pyre 
phosphate and 30 mCi of technetium-99m. supine galed 
blood peal images were acqutred in the anterior and left 
anterior oblique views. The !iming of the first hame of the 
sctm corresponded to the peait of the R wave of the electro- 
cardiograni. whicl! was recorded simullan@ously on Ihe 
pressure tracings. The acqucsttiona were then normalized 1C 
the frame with the maxim&l number of counts. A time- 
activity curve was constructed by using a semiautomated 
edge detection method with a variable region of interest. 
Rackground count density was calculated from an area of the 
frame ad]acent lathe lefl ventricle, and subtracted from each 
frame. The time-activity curve was smoothed by using a 
3-point weighted moving average (coefficients: 0.25, 0.50, 
0.25). Ejection fraction was calculated as (End-Diastok - 
End-Systolic Councl)/End-Diaslolic Counts. 
Baseline !rf vcnrriculor end-&s!& volomc was calcu- 
lated from the anterior and left anterior oblique views using 
a previously validated geometric biplane area-length method 
(32). Volumes at other points m [he cardiac cycle and during 
subsequent scans were calculated from the left anterior 
oblique scan as the ratio of counts in a given frame to those 
in the baseline end-diastolic frame muftip!ied by the baseline 
end-diastolic volume. The number of counts in scan% subse- 
quent to the baseline scan were corrected for differences in 
acquisiticn tmx and frame duration as well as for physical 
and biologic decay of the isotope. 
Prwure-voiume analysis. Left ventricular presson mea- 
surements from 4 or 5 representative beats were traced and 
digitized at a sampling interval of 2 ms on a Summagraphics 
MM1812 Bitpad interfaced lo a VAX 780 computer. The 
preswc wds iircn avct+cG ai iniervais corresponding K: !‘I< 
frame interval of the mdivnuclidc scan. Presstae-volume 
loops were constructed from these pressures plotted with the 
carrez*ccdin- volumes r a 
The end-sysrolic pressure-volume r&ion was con- 
structed from the two baseline measurements and the mea- 
surements taken during nitroprussidc infusion by the itera- 
tive method of Kass et al. (33). A line was fit lo the points in 
each cardiac cycle for which ‘he r&o of pressure to volume 
(VI was maximized. To avoid giving disproportionale weight 
to the two baseline measurements, they were each given a 
weight half &al of the measuremeat during nirroprussidc 
infusion (25). Tic volume at the extrapolated zero pressure 
(V,) was then subtracted from each volume in the cardiac 
cycle. A similarly weighted line was again fit from the points 
in the cardiac cycle for which (leR ventricular pressure)@ - 
V,) was maximized. The new V, was again subtracted from 
all the puinls in the cardiac cycle, and the process repeated 
uniil there was no significant change in either the slope OF the 
line or V,. WC have previously shown (24) that the end- 
systolic pressure.volume relation is linear in patier.:s with 
hearI failure in the range of end-systdie pressures and 
volumes ob:aizxd in tbc baseline state and during graded 
infusion cf nitmprusside. ihis !incsrity allowed us to ap- 
proximate tlte relation by using or&y tW0 aftCr&xd con&- 
tions, an important consideration in view of the time con- 
straints inherent in a left heart catheterization study. 
A rhnnge in feJf venfricolor dis!errsibiliry &ring rrirro- 
prussidr or otrial norrirrrek pepridc infrtsion IWS defilled as 
a left ventricular pressure change ~3 rntfi Hg from baseline 
during lhe period of overlap of the passive pm-lions of the 
diastolic pressure-volume relations. Because right atrial 
pressure has been shown 10 approximate intrapericardial 
pressure (341, the diasiolic Wanemural pressure-volume rc- 
lation was created by plotting left ventricular intracavitary 
pressure minas right a!rial pressure versus volume. The 
end-diastolic pressure-volume relation was constructed from 
left ventricular end-diastolic pressure and volume during the 
two baseline periods and during nitroprusside infusion. An 
exponential function was fit to these points. with the two 
baseline periods given half the weight of the nitroprusside 
period. 
Stitisks. Results are expressed as mean value ?; SEM. 
Compatisons among the four treatment periods were made 
by two-way analysis of variance, and subsequent compari- 
sons of group means by the Newman-Keuls test with a 
significance level of 0.05. 
Results 
Baseline measurements (Table I). Baseline left ventricu- 
lar end-diastolic pressure was elevated at 24 % 2 mm Hg and 
cardiac index depressed at 2.0 t 0.2 literslmin per ml. The 
baseline left ventricular end-diastolic volume of 327 2 29 ml 
indicates marked left ventricular dilation. The:e were no 
significant differences between tne two baseline periods in 
x; of th- measured or derived variables. 
Hemndynamic responses In nilroprnsside and atrial nat& 
urelic peptide (Table I). During nitroprusside infusion (79 * 
13 &min). mean systemic an&d, right atrial, pulmonaiy 
artery and pulmonary capillary wedge pressures and sys- 
temic and puhnonary vascular resistances all decreased, 
while heart rate increased slightly. Left ventricular end- 
dixtolic pressure decreased from 24 e 2 io I3 * 3 mm Hg (p 
< 0.01). while cardiac index increased from 2.0 z! 0.2 to 2.4 
2 0.2 literslmin per m* (p < 0.01). Left ventricular end- 
diastolic and r;nd-systolic volumes decreased. 
infwion oJ’arriaf norrictrclicpeplide (0.1 + 0.05 +bgl&g pPr 
minJ also rendted in decreases in mean systemic arrerial, 
right afrial, ~lulmonary artery and pulmonary capiflary 
wedge pressures. Systemic vascular resistance decreased 
but pulmonary vascular resistance was unchanged; hean 
rate was unchanged. Left ventricular end-diastolic pressure 
decreased from 24 i 2 to 16 i 3 mm Hg (p < O.Ol), while 
cardiac index iocrcased from2.0 -c 0.2 to2.4 2 O.Zli?orslmin 
per m’ (p < 0.01). As during nitroprusside infusion, left 
ventricular end-diastolic and end-rystolic volumes de- 
creased. 
Elfects on contractile function. Peak positive left ventric- 
ular dP/dt was unchanged bv either njtroarusside or atria1 
natriureIk peptide (Table i). Similarly,’ neither ejection 
fraction nor srloh work index changed significantly during 
infusion of either agent. The resuits of !eft ventricular 
end-systolic pressure-volnme analysis are depicted ir. P&e 
1. There was no shift away from the baseline end-s#olir 
prc~~~ie~volune relation during 9tial natriuretic pcptide 
iniuslon in Patient 2, a slight leftward shift in Patients I, 3.7 
and 9 and a slight rightward s&f? in Patients 4, 5, 6 and 8. 
‘This analysis indicates no consistent inotropic e5ect of atrial 
natriuretic peptide at the doxs studied. 
Elects IJO diastolic fonctioa. Peak negative left ventricu- 
lar dP/dt was unchanged during nitroprusside and atrial 
natriurelic peptide infusion (Table I). The time constant T, 
decreased with both agents, whereas T, decreased only with 
nitxptmside. Neither agent affected peak filling rate. 
There was insufficient overlap of the diastolic pressure- 
volume relations during the first baseline period and nitro- 
prusside infusion to allow meaningful assessment of a 
change in left ventricular distensibility in eight of nine 
patients. In the remaining patient. who did have sufficient 
overlap of the diastolic pressure-volume relations, the rela- 
tion was shined upward during nitroptusside infusion. The 
diistolic pressure-volume relation during atdal nabiuretic 
peptide infusion overlapped with the relation during the 
second baseline oericd in four of the nine or&ems. In rhrre 
of these four pkents (Patient* I, 4 and 9), the relation 
shifted downward during atrial natriuretic oedide infusion, 
whereas there was no shift in Patient 8 (Fig.-2). When left 
ventticulat volume was plotted against lefi ventricular pres- 
sure minus right atrial pressarc (an approximation of tmns- 
mural left ventricular pressure.), the downward shifts ob- 
served during atrial natriuretic peptide iofusion in three 
patients decreased in magnitude but were not eliminated. 
Figure 3 demonstrates that the CJOUP mean end-diastolic 
pr&re-volume point during atriG &iurets peptide infu- 
sion was not shifted relative to the expneollal end-diastolic 
pressure-volume relation derived from the dam obtained 
during the baselise and nitropnisside periods. 
Side eff~z. Three patients com+ned of Bwhir:g bring 
the citroprusside infusion. There were no side effects of 
atria1 vatriore!lc peptide it&ion. 
Previous s!udies have assessed the iwtropic effect of 
atrial natriuretic peptide in experimental models. Wangler et 
al. (20) demonstmted a negative inatropic effect of atrial 
natriuretic peptide in the isolated perfused heart ati attrib 
uted dte effect to corona?: vasoconntriction. In the intact 
circulation, the direct inotropic action of a substance with 
vasoditator properties is di5icult to separate fmm e&cts 
mediated by aberation &loading conditions. The decrease in 
stroke volume noted in reveral studies oi atrial natriuretic 
wptide (6-10.12.13~ could be due to an associated decreane 
in preload. However, in both anesthetized and conscious 
dogs, Kleinen et al. (II) observed a decrease in cardiac 
output with no alteration of Nbng pressure. Similarly, Volpe 
et al. (7) found that &at na:riuretic peptide decreared 
cardiac output without signihcant!y changing filling pressure 
in patients with hyperiension. In wntram, Fatei arui Hinlre 
(21) maintained preload constant during atrial natriuretic 
peplide infusion by aortic occlusion in conscious dogs, and 
observrd no change ir. peak left ventricular d?/dt. 
Brcsuce of the influence of load a? many mr~jucs of 
ventricular >ystolic performiurce. we utiliad the irli ventric- 
ular and-systolic pressur.wolume relation, a relaiively load- 
independat measu cf ccntractile function (22,231. to as- 
sess the inotrapic effecr of ahial natriur&c peplide in 
patients with heart f&tire. We found that atria1 natriuretic 
peptide did na :onsistemly shift the relation bttween end- 
systalic pressure and volume letward (indicating a positive 
&tropic Gecti or ri&uard (indiaring a ncg&c effeu) in 
these palients. Rather. we observed small shit& that seemed 
random!y distributed leftwa:J (four patients) and rightwrd 
(four palierxr.) from the bas&e end-aystnlic pressare- 
Volume rzlation. The sensilivity of our techaqw for detect- 
ing iwircpic effects is evident fram previou studxa show- 
ins a leftward shiR of the end-sysiclis pressuevolume 
r~laiior, in eight of nine pnticnts waled with the phosphodi- 
esterasc iahibitor enoximone ;?5) and a nghtward shift in I2 
of I4 patiems treated iKith the ca!cidm channel blocker 
nicardibirte (26:. In rhe prcsenl sludy, the relation betwa 
end-systolic pressure and volume during atrial natriuretic 
peptidc infusion was indistinguishable from iha predicted 
for a pure vawdilator with ao effect on contractih fnnctior.. 
Lack of inotropic OEM of atrut natriureiir pptidr. Be- 
cawe of the time cons:raints inherent ia a left heart cathe- 
terization study, we did not mdependently wry afterload 
during atrial n;rlritvetic pegtide infusion. and thus did not 
attempt to construct the fo!l wd-systolic pressure-volume 
relation on atrial natriuretic peptidc. We therefore cannot 
draw cuxlusions regarding the rlope 2nd volume intercept 
of the relation doring infusion of the pptide. The relative 
Meets of inotropic interventions on the 4ope and intercept 
of the end-:;ystolic pressure-volume relation depend on the 
model studied (35.36). We reasoned instead timt a positive 
ino:mpic effwt would result in a smaller end-systolic volume 
for ally given end-systolic pressure and that a negative 
inotropic effect would be associated with a larger end- 
Figure 3. Effects of nitroprusside IBI and atrial natri- 
cretic otol,de 1.1 on the reldion between Ie” vewic- 
systohc volume for any pressure. We cannot exclude the 
possibility, however unlikely, that the slope and imercept of 
the end-systolic pressure-volume relation on atrial natri- 
urelic pepride changed in such a way [hat it intersected the 
baseline relation at a point very close to that obtained for 
each patient during infusion of the peptide. 
Corroborative evidence for the lack of an inotropic effect 
of atiial natriuretic peptide comes from the observalion that 
left ventricular stmke work index. ejection fraction ax peak 
positive d?/dt did not change signiticantl) during infusion of 
the peptide. However, there ejection phase and isovolumet- 
ric indexes of contractile function are sufficiently load de- 
pendent that conclusions front them must be drawn with 
caution. An ahemativc method af evaluating the inntropic 
effect of an agent independent of changes in loading condi- 
tions is the intracoronary infusion techsique. Applying this 
method m patients with normal left ventricular systolic 
function, Herrmann et al. (37) found that attial natriuretic 
peptide had no inotropic effect when administered in doses 
that did net alter landing conditions. 
E&t OS atrial nntrhtretic ncntide on dir&& function. In 
most studies, the administra&~ of atrial uatriuretic peptide 
to animals and humans has resulted in a decrease in filling 
pressures, whether s;:!oiic functton is normal (3,14) or 
depressed (3,14-18). Although venodilation or fluid shifts to 
the cxtravaicular comPartmcnt, or both. may account for 
the decrease in filling prcssurcs. it is also possible that an 
improvement in diastolic myocardial properties contributes 
to this effect. Meulemans et al. (19) demonstrated that atrial 
natriuretic peptide induces early relaxation of trolated cnt 
papillary muscles. Hemnnnn et cl. (37) found that atria1 
natriurctic peptide shortened the time constant of isovolu- 
metric relaxation in patients with nomud ventricular func- 
tion. Because patientr with heart failure due to systolic 
dysfunction may also have abnormalities of diastolic func- 
tion (28,38), it is possible that the overall impmvement in 
vcntricuiar function brought about by atrial natrluretic pcp- 
tide in these patients is due in part to a bew,licial effect on 
diastolic myocsrdial pefiormanee. 
Evalustion of diastolic function in humans is difficult 
because availalale indexes assess different asnects (relax- 
ation, filling, stiffness) of diastolic function. Putthermore, 
indexes of diastobc function. like indexes of svstolic func- 
tion, may be afiectcd by loading conditions (Zi.39-41). In 
fact, previous srudies (28,40.42) have demonstrated beneli- 
cial effects of the “pure” vasodilator nitroprusside on in- 
dexes of diastelir function in patients with heart failure. We 
reasoned that a direct efcct of atrial natriurctic peptide on 
diastolic myocardial properties would be manifested as an 
effect beyond that of nitroprusside, and therefore. compared 
the influences of these two agents on indexes cf diastolic 
function. 
Left ventricular peak negative dP/dt was unchanged with 
administration of nitropmsside or atrial natriuretic pcptide. 
Both T, and T, decreased with nhroprusside, whereas only 
T, decreased significantly with atrlal natriurctic peptidc. 
Thus, the e5ect of atria1 nahiuretic peptide on indexes cf 
relaxation was no greater than that of nitroprusstde. We 
attribute the decrease in T, with both agents to a downward 
translation of the ventricular pressure curve, which obligates 
a shortening of the time cunstant of relaxation in a model 
that constrains the pressure asymptote to be zero (43). A 
similar finding of a decrease in T, with no efec! on Tnduring 
atrial natriuretic oeotide infusion was rcoorted bv Herrmann . 
et al. (37) in patients with normal left ventricu)ar function. 
Changes in loading conditions with reduction of left vcntric- 
ular end-systolic volume may also a&t isovolutnctric rc- 
laxation in patients with heart failure, accounting for the fall 
in T, with nitroprusside (28.41). Peak filling rate was un- 
changed with both nitroprusside and atria1 natriureric pep- 
tide. It is possible that e tendency toward improved filling 
with both medications was countcrbalauccd by the cancorn- 
itant decrease in pulmonary capillary wedge prcwre. which 
reflects the driving force for early diastolic filling (27,453. 
Overnil /eft ventricular dismsibilily throughout dimrole 
is best assessed by the pressure-volume relation. Marked 
decreases in ventricular volume prevented comparison of 
diastolic pressure over a cornmod range of volume for the 
first baseline and nitroprusside periods in eight w!iem~ and 
for the second baseline and atrial natriuretic peptide periods 
in five patients. Of the four patients in whom the position of 
the diastolic prcswe-vohune relation during atrial natri- 
uretic pcptide infusion could be compared with that during 
the second baseline period. n downward shift of the relation 
was observed in three. This effect was lessened but not 
abolished when the oressure-volume relations were rcplot- 
ted by using estimaied bansmural pressure. In a previous 
study (28) of patients with heart faiiurc, similar downward 
shifts during administration of nitroprusside were also not 
comnktclv aboiished after “correction” for rinht ahiai ores- 
sure: Bee&c eornnaty blood flow increases in paticnt;with 
coronary stenosis (4.5) and is not significantly altered by 
atrial natrlurctic pcptide in patients with heart failure (17). 
w cannot attribute lhc residual improvement o a decrease 
in coronary torpor. The affect of atria1 natriuretic pcptide on 
the relation hetwcen end-diastolic prcssttrc and volume was 
not significantly different from that of nitroorosside. 
Ov&N. rhe.effecrr of olrial norrimric p&ride on indexes 
of diasrolit myocardiol function were similar to those of 
nitroprusside. Thus, we found no specific influence of the 
pcptide on myocardial contra& or diastolic function in 
patients with heart failure. Additional evidence for the lack 
of direct myocardial actions of atrial nalriurcttc popttdr 
eomeb from the radioautographic localization studies of 
Bianchi et al. (46). in which the peptide was fottnd to hind to 
the endothelial cells of the rat heart but not to ventricular 
myoeytcs. 
Limitations of the study. The limitations imposed by the 
time constraints inherent in a left heart catheterization study 
have already been acknowledged. Several other limitations 
of this study need to be considered. First, although cardiac 
medications were withheld for 12 to 24 h b&ore study, it is 
conceivable that residual effects of these drugs oould modify 
the etieets of atrial natriurctic peptidc on the tnyoeardium. 
Second. it is possible that a change In autonomic tone 
cwurrinadcring either atrlrd natrioretic wotide ornitroorus- 
side inf&on thay have affected myoc&dial contracthe or 
diastolic function, or both. Although we did not mcawrc 
plasma eatecholarnine conceotrations in this study, previous 
studies (47) in which nitroprusside was administered to 
patients with heart failure did not reveal r change in sympa- 
thetic tone as measured by plasma norcpinephrinc and 
epincphrine levels. However, heart rate did increase slightly 
with nilropntsside in our study group. Third, the study 
patients had severe IeR ventricular syEIoIic dysfuncdon. It is 
possible that atrial natnuretic pepude wuld affect left 
ventricular contrxtile or diastoiic function in patient, with 
less profound heart failure. 
Finally, studies (48.49) in wnscious animals have %UB_ 
gested that phamxcologic manipulations of vectricular Iwad- 
ing conditions with agents such as nilroprasside may alter 
the end-systolic pressure-volume relation despite autonomic 
blockade. We have attempted to achieve steady srate alter- 
ation in loading conditions in palients with heon fmlure hy 
baU.lloon occlusion of ihe inferior vena cava in lieu of mwo- 
prusside infusion. but have been unable to lowr artenal 
&ssure sufficiently by this method IO reliably construct rhe 
end-systali: pressure-volume relation. The drvelopment at’ 
methods to reliably determine ventriculdr volumes on a beat 
to beat basis in patients with heart failure may ailow the use 
of mechanical techniques 10 con~lr~ct the end-systolic prca- 
sure-volume relation. 
Concluslans. The administration of atria1 natriuretic LED- 
tide lo patients with hean failure due to systolic dysfun&n 
results in improved pump performance. manifested as an 
augmentation of forward output and a decrease in tilling 
pressures. 7% improvement is not associate; with a change 
in myocardial contractile function. Change? in indexes of 
diastolic function with atrial natriuretic peptide infusion arc 
similar 10 those that occur with nitmprusside, and are most 
likely mediared by an alteration in loading condaions rather 
than a direct eiIect oa myocardial diastolic properties. WC 
conclude lh31 Ihe beneficial effects of alnal nalriuredc pep 
tide on ventricular fun&n in patiems with chronic heart 
failure rest& from favorable changes in ventricular load 
without alterations in myocardial properties. 
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